Researchers have identified a blood test that may help predict how severely a baby will be affected by alcohol exposure during pregnancy, according to a study published November 9 in the journal PLOS ONE.
The study authors, from the University of California San Diego School of Medicine, Texas A&M College of Medicine and the Omni-Net Birth Defects Prevention Program in Ukraine, say the findings could facilitate early intervention to improve the health of infants and children who were prenatally exposed to alcohol, according to a UC San Diego news release.
Co-authors of the paper include: Sridevi Balarama, and Alexander M. Tseng, Texas A&M Health Science Center; and Lyubov Yevtushok, and Natalya Zymak-Zakutnya, Omni-Net Ukraine Birth Defects Prevention Program.
Funding for this research came, in part, from the National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism (grant numbers U01AA014835, U24AA014811, R01AA013440) and the Collaborative Initiative on Fetal Alcohol Spectrum Disorders.
Above, NIAAA scientists Drs. Olivier Soubias, Klaus Gawrisch, and Walter Teague (L-R) are pictured in the room that was specially constructed to house the “big magnet.” This device is powerful enough to resolve protein structures but is also so sensitive that it needs to be protected from temperature changes and vibrations in order to produce accurate data.
Reprinted from the NIAAA Spectrum, Volume 8, Issue 2, June 2016.
The concept of addiction as a brain disease is still being questioned. Yet, an article published in The New England Journal of Medicine by NIDA Director Dr. Nora Volkow, NIAAA Director Dr. George Koob, and Dr. A. Thomas McLellan, co-founder and Chair of the Board of the Treatment Research Institute, further enforces this concept. The review article summarizes recent scientific advances in the neurobiology of addiction....
Read the announcement at https://www.drugabuse.gov/news-events/news-releases/2016/01/review-artic....
- Reference: "Neurobiologic Advances from the Brain Disease Model of Addiction" by Nora D. Volkow, M.D., Director, National Institute on Drug Abuse, George F. Koob, Ph.D., Director, National Institute on Alcohol Abuse and Alcoholism, and A. Thomas McLellan, Ph.D., Co-founder, Treatment Research Institute, published online January 28, 2016 in The New England Journal of Medicine.